相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients
Y. Gonzalez-Lama et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Khurram J. Khan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Guidelines for the management of inflammatory bowel disease in adults
Craig Mowat et al.
GUT (2011)
Severe CMV-related Pneumonia Complicated by the Hemophagocytic Lymphohistiocytic (HLH) Syndrome in Quiescent Crohn's Colitis: Harmful Cure?
Maria A. Lo Presti et al.
INFLAMMATORY BOWEL DISEASES (2011)
Azathioprine Is Effective in Corticosteroid-dependent Asian Inflammatory Bowel Disease Patients
Kelvin T. Thia et al.
INFLAMMATORY BOWEL DISEASES (2011)
Use of Thiopurine Testing in the Management of Inflammatory Bowel Diseases in Clinical Practice: A Worldwide Survey of Experts
Xavier Roblin et al.
INFLAMMATORY BOWEL DISEASES (2011)
C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis
Dan Turner et al.
JOURNAL OF CROHNS & COLITIS (2011)
The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients
Guillermo Bastida et al.
BMC GASTROENTEROLOGY (2010)
Response to Medical Treatment in Patients with Crohn's Disease: The Role of NOD2/CRAD15, Disease Phenotype, and Age of Diagnosis
B. Weiss et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Significant Differences Between Crohn's Disease and Ulcerative Colitis Regarding the Impact of Body Mass Index and Initial Disease Activity on Responsiveness to Azathioprine: Results from a European Multicenter Study in 1,176 Patients
Martin H. Holtmann et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates
A. V. Ramadas et al.
GUT (2010)
Thiopurine Therapy in Inflammatory Bowel Disease Patients: Analyses of Two 8-Year Intercept Cohorts
B. Jharap et al.
INFLAMMATORY BOWEL DISEASES (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Timing of Myelosuppression During Thiopurine Therapy for Inflammatory Bowel Disease: Implications for Monitoring Recommendations
James D. Lewis et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold
Sharon J. Gardiner et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease
L. Y. Kwan et al.
DIGESTIVE AND LIVER DISEASE (2008)
The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice
S. Saibeni et al.
DIGESTIVE AND LIVER DISEASE (2008)
How are azathioprine and 6-mercaptopurine dosed by gastroenterologists? Results of a survey of clinical practice
Jason S. Yip et al.
INFLAMMATORY BOWEL DISEASES (2008)
European evidence-based Consensus on the management of ulcerative colitis: Current management
S. P. L. Travis et al.
JOURNAL OF CROHNS & COLITIS (2008)
Lower doses of 6-mercaptopurine/azathioprine bring enough clinical efficacy and therapeutic concentration of erythrocyte 6-mercaptopurine metabolite in Japanese IBD patients
Takako Komiyama et al.
JOURNAL OF CROHNS & COLITIS (2008)
Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: Open-label prospective study
Julio Maria Fonseca Chebli et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease
U. Hindorf et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Review article: thiopurines in inflammatory bowel disease
L. J. J. Derijks et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
RBC 6-TGN and hematological parameters in patients with Crohn's disease treated by azathioprine
PN d'Halluin et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2005)
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
CA Solem et al.
INFLAMMATORY BOWEL DISEASES (2005)
Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations
AFY Al Hadithy et al.
DIGESTIVE AND LIVER DISEASE (2005)
Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: Effect on cost and adverse events
FA Sayani et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Review article: monitoring of immunomodulators in inflammatory bowel disease
FN Aberra et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease
S Wright et al.
GUT (2004)
Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid-dependent ulcerative colitis
A Lopez-Sanroman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Indicators of clinical response to treatment with six-mercaptopurine or azathioprine in patients with inflammatory bowel disease
JP Achkar et al.
INFLAMMATORY BOWEL DISEASES (2004)
Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine
CW Thomas et al.
INFLAMMATORY BOWEL DISEASES (2003)
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
AG Fraser et al.
GUT (2002)
Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine
OH Nielsen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
PW Lowry et al.
GUT (2001)
Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease
J Belaiche et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
J Markowitz et al.
GASTROENTEROLOGY (2000)
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
JF Colombel et al.
GASTROENTEROLOGY (2000)
Relationship between red cell mean corpuscular volume and 6-thioguanine nucleotides in patients treated with azathioprine
G Decaux et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2000)
分享论文
